Drug-device Combination Products Market, by Product Type (Drug Eluting Stents  (Coronary Stent, and Peripheral Vascular Stents), Infusion Pumps (Implantable and Ambulatory), Photosensitizers, Orthopedic Combination Products, Wound Care Combination Produ

Drug-device Combination Products Market, by Product Type (Drug Eluting Stents  (Coronary Stent, and Peripheral Vascular Stents), Infusion Pumps (Implantable and Ambulatory), Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers (Dry Powder Inhaler, Nebulizers, and Metered Dose Inhaler)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Drug device combination products consist of drugs administered or delivered through specialized devices to the patients. Examples of such products include prefilled syringes, infusion pumps, drug coated devices such as stents, and others. Manufacturers such as Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, Integer Holdings Corporation, Abbott Laboratories, and others offer drug device combination products in the market.
Market Dynamics
Market players are focusing on various inorganic growth strategies such as mergers and collaborations to strengthen their position in the global market. This is expected to drive growth of the global drug-device combination products market during the forecast period. For instance, in 2021, Boston Scientific Corporation acquired BTG plc. BTG plc. develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, coupled with specialty pharmaceuticals.
Rising launch of new advanced products by the market players is expected to drive the global drug-device combination products market growth over the forecast period. For instance, in February 2020, Flowonix Medical, Inc. received the U.S. Food and Drug Administration approval for its Prometra II Programmable Pump System for use with intrathecal baclofen.
Key players operating in the market are focused on conducting clinical trials for approval and launch of novel combination drug eluting stents, which is expected to drive the market growth over the forecast period. For instance, in July 2021, SINOMED completed enrollment in the PIONEER III randomized, controlled clinical trial to assess the safety and effectiveness of the BuMA Supreme DES in order to obtain key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System.
Key features of the study:
This report provides in-depth analysis of the global drug-device combination products market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global drug-device combination products market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., AbbVie Inc., Abbott Laboratories, Medtronic Plc., Kaleo, Inc., SINOMED, Becton, Dickinson and Company, Alcon Inc., Boston Scientific Corporation, Integer Holdings Corporation, Teleflex Incorporated, Bausch Health Companies Inc., Haselmeier GmbH, and Flowonix Medical, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global drug-device combination products market report caters to various stakeholders in this industry including investors, suppliers, drug-device combination products manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global drug-device combination products market
Detailed Segmentation
Global Drug-device Combination Products Market, By Product Type:
Drug Eluting Stents
Coronary Stent
Peripheral Vascular Stents
Infusion Pumps
Implantable
Ambulatory
Photosensitizers
Orthopedic Combination Products
Wound care Combination Products
Inhalers
Dry Powder Inhaler
Nebulizers
Metered Dose Inhaler
Global Drug-device Combination Products Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Drug-device Combination Products Market, By Region:
North America
By Country
U.S.
Canada
By Product Type
Drug Eluting Stents
Coronary Stent
Peripheral Vascular Stents
Infusion Pumps
Implantable
Ambulatory
Photosensitizers
Orthopedic Combination Products
Wound care Combination Products
Inhalers
Dry Powder Inhaler
Nebulizers
Metered Dose Inhaler
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type
Drug Eluting Stents
Coronary Stent
Peripheral Vascular Stents
Infusion Pumps
Implantable
Ambulatory
Photosensitizers
Orthopedic Combination Products
Wound care Combination Products
Inhalers
Dry Powder Inhaler
Nebulizers
Metered Dose Inhaler
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type
Drug Eluting Stents
Coronary Stent
Peripheral Vascular Stents
Infusion Pumps
Implantable
Ambulatory
Photosensitizers
Orthopedic Combination Products
Wound care Combination Products
Inhalers
Dry Powder Inhaler
Nebulizers
Metered Dose Inhaler
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product Type
Drug Eluting Stents
Coronary Stent
Peripheral Vascular Stents
Infusion Pumps
Implantable
Ambulatory
Photosensitizers
Orthopedic Combination Products
Wound care Combination Products
Inhalers
Dry Powder Inhaler
Nebulizers
Metered Dose Inhaler
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product Type
Drug Eluting Stents
Coronary Stent
Peripheral Vascular Stents
Infusion Pumps
Implantable
Ambulatory
Photosensitizers
Orthopedic Combination Products
Wound care Combination Products
Inhalers
Dry Powder Inhaler
Nebulizers
Metered Dose Inhaler
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Product Type
Drug Eluting Stents
Coronary Stent
Peripheral Vascular Stents
Infusion Pumps
Implantable
Ambulatory
Photosensitizers
Orthopedic Combination Products
Wound care Combination Products
Inhalers
Dry Powder Inhaler
Nebulizers
Metered Dose Inhaler
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Company Profiles
Teva Pharmaceutical Industries Ltd.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
AbbVie Inc.
Abbott Laboratories
Medtronic Plc.
Kaleo, Inc.
SINOMED
Becton, Dickinson and Company
Alcon Inc.
Boston Scientific Corporation
Integer Holdings Corporation
Teleflex Incorporated
Bausch Health Companies Inc.
Haselmeier GmbH
Flowonix Medical, Inc.
“*” marked represents similar segmentation in other categories in the respective section.